食物碗与听诊器图标

治疗性营养

关于具有营养敏感健康状况的猫犬的需求的实用信息。

肾脏和泌尿系统疾病

猫慢性肾病 (CKD)

10 岁以上的猫中约有三分之一被诊断为慢性肾病。1,2 在猫中,尽管存在与品种相关的 CKD 病因,例如波斯猫常见的多囊肾病,但病因通常是特发性的。3 根据国际肾脏病学会 (IRIS) 制定的指南,可基于临床检查和实验室检查对猫的 CKD 进行“分期”,并结合医疗和治疗性饮食进行管理。

CKD 患猫的营养管理有四个总体目标:维持充足的营养;减轻 CKD 的临床后果,包括 尿毒症体征;解决因肾功能障碍导致的 体内稳态 变化;减缓疾病进展并延长寿命。4 虽然这种疾病具有渐进性,但个体化的医疗和营养管理可以帮助许多 CKD 患猫存活多年。5 

猫肾脏紫色图标
你知道吗?

虽然对于人类 CKD 患者,通常会限制饮食中的钠摄入量,但猫的相关证据表明这样做不仅没有必要,而且过度限制可能有害。2,10

重要信息


  • 营养状况的连续评估以及为患宠定制的营养计划对于护理至关重要。6 
    • 评估肌肉质量尤为重要,因为肌酐在肌肉质量下降的患宠中可能会产生误导性偏低的结果。7  
    • 瘦体重的流失与衰老和 CKD 所致的死亡率增加有关。5,7 
  • 确保摄入足够的热量。如果能量需求得不到满足,身体组织就会发生分解代谢,导致瘦体重流失,并增加 CKD 患猫的发病和死亡风险。8  
    • 避免对患猫进行不必要的饮食改变,以降低因厌食症而导致拒绝特定饮食的风险。需要改变饮食时,请在猫感觉良好的情况下逐步进行。6  
  • 关键营养因素包括磷、蛋白质、钾、Omega-3 脂肪酸和碱化缓冲液。对于中度至重度 CKD 患猫,治疗性肾脏饮食比成年猫维持期饮食更有利于临床结果(生存期更长,尿毒症危象更少)。4,9-12   
    • 在 CKD 和高磷血症患猫中,磷的调节作用被破坏,并伴随甲状旁腺激素 (PTH) 或 成纤维细胞生长因子23 (FGF23) 的升高,进一步加剧了现有肾脏疾病带来的持续损伤。根据 IRIS 分期,通过限制饮食中的磷摄入量和使用磷酸盐结合剂来管理血清磷酸盐水平。4 
  • 猫需要高蛋白质含量的饮食,老年猫的需求量则更高。目的是避免蛋白质摄入不足进一步加剧瘦体重流失,同时也要避免过量摄入。6  
    • 根据现有证据,对于 CKD 患猫而言,限制蛋白质摄入本身并不必要。10 
    • 在 CKD 早期阶段维持较高的蛋白质水平可能有助于保持瘦体重。13-15  
    • 后期阶段的适度蛋白质摄入限制可能有助于减少含氮废物的积累。4  
  • 维持充足的钾对正常肾功能至关重要,低钾会导致 CKD 或使 CKD 恶化。6  
    • 大多数治疗性肾脏饮食均会补充钾,但应定期监测 CKD 患猫的血钾水平。16-19  
  • 通常建议为 CKD 患猫补充鱼油中的 Omega-3 脂肪酸。10,11, 20  

与宠物主人分享:

评估您爱猫的身体状况

只需 3 个简单的步骤即可评估您的爱猫的身体状况。

观看视频 1 分钟至 5 分钟

参考文献

  1. Lulich, J. P., Osborne, C. A., O’Brien T. D., & Polzin, D. J. (1992). Feline renal failure: Questions, answers, questions. Compendium on Continuing Education for the Practicing Veterinarian14, 127–152.
  2. Sparkes, A. H., Caney, S., Chalhoub, S., Elliott, J., Finch, N., Gajanayake, I., Langston, C., Lefebvre, H. P., White, J., & Quimby, J. (2016). ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease. Journal of Feline Medicine and Surgery18(3), 219–239. doi: 10.1177/1098612X16631234
  3. Brown, C. A., Elliott, J., Schmiedt, C. W., & Brown, S. A. (2016). Chronic kidney disease in aged cats: Clinical features, morphology, and proposed pathogeneses. Veterinary Pathology53(2), 309–326. doi: 10.1177/0300985815622975
  4. International Renal Interest Society (IRIS). (2019). IRIS staging of CKD (modified 2019). http://www.iris-kidney.com/pdf/IRIS_Staging_of_CKD_modified_2019.pdf​
  5. Boyd, L. M., Langston, C., Thompson, K., Zivin, K., & Imanishi, M. (2008). Survival in cats with naturally occurring chronic kidney disease (2000–2002). Journal of Veterinary Internal Medicine, 22(5), 1111–1117doi: 10.1111/j.1939-1676.2008.0163.x​
  6. Quimby, J. M. (2016). Update on medical management of clinical manifestations of chronic kidney disease. Veterinary Clinics of North America: Small Animal Practice46(6),1163–1181. doi: 10.1016/j.cvsm.2016.06.004
  7. Freeman, L. M., Lachaud, M. P., Matthews, S., Rhodes, L., & Zollers, B. (2016). Evaluation of weight loss over time in cats with chronic kidney disease. Journal of Veterinary Internal Medicine30(5), 1661–1666. doi: 10.1111/jvim.14561
  8. Larsen, J. A. (2016). Controversies in veterinary nephrology: Differing viewpoints: Role of dietary protein in the management of feline chronic kidney disease. Veterinary Clinics of North America: Small Animal Practice46(6), 1095–1098. doi: 10.1016/j.cvsm.2016.06.012
  9. Elliott, J., Rawlings, J. M., Markwell, P. J., & Barber, P. J. (2000). Survival of cats with naturally occurring chronic renal failure: Effect of dietary management. Journal of Small Animal Practice41(6), 235–242. doi: 10.1111/j.1748-5827.2000.tb03932.x
  10. Laflamme, D., Backus, R., Brown, S., Butterwick, R., Czarnecki-Maulden, G., Elliott, J., Fascetti, A., & Polzin, D. (2020). A review of phosphorus homeostasis and the impact of different types and amounts of dietary phosphate on metabolism and renal health in cats. Journal of Veterinary Internal Medicine34(6), 2187–2196. doi: 10.1111/jvim.15961
  11. Plantinga, E. A., Everts, H., Kastelein, A. M., & Beynen, A. C. (2005). Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Veterinary Record157(7), 185–187. doi: 10.1136/vr.157.7.185
  12. Ross, S. J., Osborne, C. A., Kirk, C. A., Lowry, S. R., Koehler, L. A., & Polzin, D. J. (2006). Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. Journal of the American Veterinary Medical Association229(6), 949–957. doi: 10.2460/javma.229.6.949
  13. Nguyen, P., Leray, V., Dumon, H., Martin, L., Siliart, B., Diez, M., & Biourge, V. (2004). High protein intake affects lean body mass but not energy expenditure in nonobese neutered cats. Journal of Nutrition, 134(8 Suppl), 2084S–2086S. doi: 10.1093/jn/134.8.2084S
  14. Noguiera, A., Pires, M., & Oliveira, P. (2017). Pathophysiological mechanisms of renal fibrosis: A review of animal models and therapeutic strategies. in vivo, 31(1): 1–22.
  15. Perez-Camargo, G. (2004). Cat nutrition: What’s new in the old? Compendium on Continuing Education for the Practicing Veterinarian, 26(S2A), 5–10.
  16. Buranakarl, C., Mathur, S., & Brown, S. A. (2004). Effects of dietary sodium chloride intake on renal function and blood pressure in cats with normal and reduced renal function. American Journal of Veterinary Research65(5), 620–627doi: 10.2460/ajvr.2004.65.620​
  17. DiBartola, S. P., Buffington, C. A., Chew, D. J., McLoughlin, M. A., & Sparks, R. A. (1993). Development of chronic renal disease in cats fed a commercial diet. Journal of the American Veterinary Medical Association202(5), 744–751.
  18. Dow, S. W., Fettman, M. J., LeCouteur, R. A., & Hamar, D. W. (1987). Potassium depletion in cats: Renal and dietary influences. Journal of the American Veterinary Medical Association191(12), 1569–1575.
  19. Theisen, S. K., DiBartola, S. P., Radin, M. J., Chew, D. J., Buffington, C. A., & Dow, S. W. (1997). Muscle potassium content and potassium gluconate supplementation in normokalemic cats with naturally occurring chronic renal failure. Journal of Veterinary Internal Medicine11(4), 212–217. doi: 10.1111/j.1939-1676.1997.tb00093.x
  20. Priante, G., Musacchio, E., Valvason, C., Clari, G., Bordin, L., Sartori, L., & Baggio, B. (2013). Further insights about the beneficial effects of n-3 fatty acids in the early molecular events of renal fibrosis in vitro. Journal of Nephrology26(4), 652–659. doi: 10.5301/jn.5000193